- KR₩33bn
- KR₩14bn
- KR₩25bn
- 57
- 40
- 29
- 33
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 23,207 | 24,589 |
Cost of Revenue | |||||
Gross Profit | — | — | — | 6,813 | 5,874 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 183 | 41 | 30.1 | 21,659 | 23,883 |
Operating Profit | -183 | -41 | -30.1 | 1,548 | 706 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -180 | 17.1 | -20.4 | -1,471 | 1,267 |
Provision for Income Taxes | |||||
Net Income After Taxes | -141 | 16.6 | -15.9 | -1,721 | 1,082 |
Net Income Before Extraordinary Items | |||||
Net Income | -141 | 16.6 | -15.9 | -1,721 | 1,082 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -141 | 16.6 | -15.9 | -1,721 | 1,082 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -53.7 | 3.31 | -3.18 | -91.4 | 46.4 |
Dividends per Share |